Evidence map›Paper›PMID 36653408›Full record

ArticleCommunications biology2023

A streamlined tandem tip-based workflow for sensitive nanoscale phosphoproteomics.

Chia-Feng Tsai, Yi-Ting Wang, Chuan-Chih Hsu, Reta Birhanu Kitata, Rosalie K Chu, Marija Velickovic, Rui Zhao, Sarah M Williams, William B Chrisler, Marda L Jorgensen and 7 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. StageTip: a little giant unveiling the potential of mass spectrometry-based proteomics.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Mapping Nanoscale-To-Single-Cell Phosphoproteomic Landscape by Chip-DIA.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Chia-Feng Tsai *Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99354, USA. chia-feng.tsai@pnnl.gov.ORCID 0000-0002-6514-6911
Yi-Ting Wang *Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99354, USA.ORCID 0000-0001-7509-2016
Chuan-Chih HsuInstitute of Plant and Microbial Biology, Academia Sinica, Taipei, Taiwan.
Reta Birhanu KitataBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99354, USA.ORCID 0000-0002-8973-7679
Rosalie K ChuBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99354, USA.ORCID 0000-0001-7428-7647
Marija VelickovicEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA, 99354, USA.
Rui ZhaoBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99354, USA.
Sarah M WilliamsEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA, 99354, USA.
William B ChrislerBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99354, USA.
Marda L JorgensenDepartment of Pathology, Immunology, and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Gainesville, FL, 32611, USA.
Ronald J MooreBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99354, USA.ORCID 0000-0003-2806-2855
Ying ZhuEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA, 99354, USA.ORCID 0000-0002-5416-0566
Karin D RodlandBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99354, USA.ORCID 0000-0001-7070-6541
Richard D SmithBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99354, USA.ORCID 0000-0002-2381-2349
Clive H WasserfallDepartment of Pathology, Immunology, and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Gainesville, FL, 32611, USA.ORCID 0000-0002-3522-8932
Tujin ShiBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99354, USA. tujin.shi@pnnl.gov.ORCID 0000-0002-5592-3588
Tao LiuBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99354, USA. tao.liu@pnnl.gov.ORCID 0000-0001-9529-6550
Pacific Northwest National Laboratory · USUniversity of Florida · USInstitute of Plant and Microbial Biology, Academia Sinica · TW

Funding

Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
Proteogenomic Translational Research Center for Clinical ProteomicU01CA214116 · NCI · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI DRUKER, BRIAN J, RODLAND, KARIN D · 2017 to 2021
$6.8M
Center for Advanced Multi-Omic Characterization of CancerU24CA271012 · NCI · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI Tao Liu · 2022 to 2026
$6.6M
A scalable mass spectrometry platform for proteome mapping of brain tissuesRF1MH128885 · NIMH · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SHI, TUJIN · 2021 to 2021
$3.7M
Targeted proteomics technology for accurate quantitative single-cell proteomicsR01GM139858 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SHI, TUJIN · 2021 to 2024
$1.6M
A streamlined platform for phosphoproteome mapping of human tissuesUH3CA256967 · NCI · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI LIU, HUIPING, SHI, TUJIN · 2022 to 2023
$1.2M
A streamlined platform for phosphoproteome mapping of human tissuesUG3CA256967 · NCI · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI LIU, HUIPING, SHI, TUJIN · 2020 to 2021
$800k
An ultrasensitive targeted mass spectrometry system for proteomics analysis of single cellsR21CA223715 · NCI · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SHI, TUJIN · 2018 to 2020
$691k
NCI NIH HHS R21 CA223715NCI NIH HHS U01 CA214116NCI NIH HHS U24 CA271012NCI NIH HHS UG3 CA256967NCI NIH HHS UH3 CA256967NIGMS NIH HHS P41 GM103493NIGMS NIH HHS R01 GM139858NIMH NIH HHS RF1 MH128885
6 · The paper itself

Abstract

Effective phosphoproteome of nanoscale sample analysis remains a daunting task, primarily due to significant sample loss associated with non-specific surface adsorption during enrichment of low stoichiometric phosphopeptide. We develop a tandem tip phosphoproteomics sample preparation method that is capable of sample cleanup and enrichment without additional sample transfer, and its integration with our recently developed SOP (Surfactant-assisted One-Pot sample preparation) and iBASIL (improved Boosting to Amplify Signal with Isobaric Labeling) approaches provides a streamlined workflow enabling sensitive, high-throughput nanoscale phosphoproteome measurements. This approach significantly reduces both sample loss and processing time, allowing the identification of >3000 (>9500) phosphopeptides from 1 (10) µg of cell lysate using the label-free method without a spectral library. It also enables precise quantification of ~600 phosphopeptides from 100 sorted cells (single-cell level input for the enriched phosphopeptides) and ~700 phosphopeptides from human spleen tissue voxels with a spatial resolution of 200 µm (equivalent to ~100 cells) in a high-throughput manner. The new workflow opens avenues for phosphoproteome profiling of mass-limited samples at the low nanogram level.

Indexed as

PhosphopeptidesTandem Mass SpectrometryHumansProteomeProteomicsWorkflowPhosphopeptidesProteome

Identifiers

PMID36653408
PMCPMC9849344
OpenAlexW4317211944

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.